1. |
Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol, 2015, 16(4): e173-e180. doi: 10.1016/S1470-2045(14)71116-7.
|
2. |
Sywak M, Pasieka JL, McFadden S, et al. Functional results and quality of life after tracheal resection for locally invasive thyroid cancer. Am J Surg, 2003, 185(5): 462-467.
|
3. |
Grubbs EG, Evans DB. Role of lymph node dissection in primary surgery for thyroid cancer. J Natl Compr Canc Netw, 2007, 5(6): 623-630.
|
4. |
秦元, 张浩. 国内外指南中甲状腺癌颈淋巴结清扫手术范围及指征变迁. 中国实用外科杂志, 2020, 40(6): 639-643.
|
5. |
So YK, Kim MJ, Kim S, et al. Lateral lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis for prevalence, risk factors, and location. Int J Surg, 2018, 50: 94-103.
|
6. |
Wang Y, Deng C, Shu X, et al. Risk factors and a prediction model of lateral lymph node metastasis in cN0 papillary thyroid carcinoma patients with 1-2 central lymph node metastases. Front Endocrinol (Lausanne), 2021, 12: 716728. doi: 10.3389/fendo.2021.716728.
|
7. |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin, 2021, 71(1): 7-33.
|
8. |
贺青卿, 于芳, 范子义, 等. 单中心2 038例甲状腺癌20年随访及危险因素分析. 中华内分泌外科杂志, 2022, 16(1): 18-22.
|
9. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016, 26(1): 1-133.
|
10. |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021. 肿瘤预防与治疗, 2021, 34(12): 1164-1200.
|
11. |
King JM, Corbitt C, Miller FR. Management of lateral cervical metastases in papillary thyroid cancer: patterns of lymph node distribution. Ear Nose Throat J, 2011, 90(8): 386-389.
|
12. |
Yang Z, Heng Y, Zhao Q, et al. A specific predicting model for screening skip metastasis from patients with negative central lymph nodes metastasis in papillary thyroid cancer. Front Endocrinol (Lausanne), 2021, 12: 743900. doi: 10.3389/fendo.2021.743900.
|
13. |
中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 分化型甲状腺癌颈侧区淋巴结清扫专家共识(2017版). 中国实用外科杂志, 2017, 37(9): 985-991.
|
14. |
Won HR, Chang JW, Kang YE, et al. Optimal extent of lateral neck dissection for well-differentiated thyroid carcinoma with metastatic lateral neck lymph nodes: a systematic review and meta-analysis. Oral Oncol, 2018, 87: 117-125.
|
15. |
Liu C, Xiao C, Chen J, et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer, 2019, 19(1): 622. doi: 10.1186/s12885-019-5835-6.
|
16. |
Liu S, Liu C, Zhao L, et al. A prediction model incorporating the BRAFV600E protein status for determining the risk of cervical lateral lymph node metastasis in papillary thyroid cancer patients with central lymph node metastasis. Eur J Surg Oncol, 2021, 47(11): 2774-2780.
|
17. |
Amit M, Boonsripitayanon M, Goepfert RP, et al. Extrathyroidal extension: does strap muscle invasion alone influence recurrence and survival in patients with differentiated thyroid cancer? Ann Surg Oncol, 2018, 25(11): 3380-3388.
|
18. |
Castagna MG, Forleo R, Maino F, et al. Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor. J Endocrinol Invest, 2018, 41(9): 1029-1035.
|
19. |
Dou Y, Hu D, Chen Y, et al. PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis. World J Surg Oncol, 2020, 18(1): 188. doi: 10.1186/s12957-020-01965-x.
|
20. |
Lee YS, Shin SC, Lim YS, et al. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer. Head Neck, 2014, 36(6): 887-891.
|
21. |
Liu Z, Liu Y, Fan Y, et al. Level Ⅱb lymph node metastasis characteristics and predictive factors for patients with cN1b papillary thyroid carcinoma. Surgery, 2020, 167(6): 962-968.
|
22. |
Feng JW, Qin AC, Ye J, et al. Predictive factors for lateral lymph node metastasis and skip metastasis in papillary thyroid carcinoma. Endocr Pathol, 2020, 31(1): 67-76.
|
23. |
江晶晶, 王建华, 丁文波, 等. FNAC联合BRAFV600E基因检测对甲状腺癌颈部淋巴结转移的诊断价值. 中国普外基础与临床杂志, 2018, 25(9): 1083-1086.
|
24. |
黄美玲, 李永平, 凌瑞. BRAFV600E基因突变与乳头状甲状腺癌淋巴结转移相关性的Meta分析. 中国肿瘤, 2017, 26(2): 145-151.
|